NCT04573907View on ClinicalTrials.gov

Bioequivalence Study of Levothyroxine Sodium Tablets 100 mcg

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

October 1, 2019

Study Completion Date

May 1, 2020

Conditions
Healthy
Interventions
DRUG

Drug Levothyroxine 100 mcg

Administration of a 600 mcg levothyroxine dose

DRUG

Drug Eutirox 100 mcg

Administration of a 600 mcg levothyroxine dose

Trial Locations (1)

Unknown

DominguezLab, Paraná

All Listed Sponsors
collaborator

DominguezLab

UNKNOWN

lead

Tecnoquimicas

INDUSTRY

NCT04573907 - Bioequivalence Study of Levothyroxine Sodium Tablets 100 mcg | Biotech Hunter | Biotech Hunter